KAITLIN WALTERS: Open Payments
NPI 1144988668 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 63 payments from 11 companies in 2025. Trend: 2023 $1,001 · 2024 $1,006 · 2025 $1,019
Food & beverage: $968Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 35 | $445 |
| Phathom Pharmaceuticals, Inc. | 9 | $188 |
| Celltrion USA Inc. | 6 | $124 |
| Madrigal Pharmaceuticals | 4 | $97 |
| Lilly USA, LLC | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| QOL Medical, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Ardelyx, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: TREMFYA, VOQUEZNA, VEGZELMA, REZDIFFRA, OMVOH, IQIRVO, Sucraid, Wegovy.
Industry payments across ND — which companies pay providers there.
